Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11266081rdf:typepubmed:Citationlld:pubmed
pubmed-article:11266081lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C0342739lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C1414645lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:11266081lifeskim:mentionsumls-concept:C0058253lld:lifeskim
pubmed-article:11266081pubmed:issue2lld:pubmed
pubmed-article:11266081pubmed:dateCreated2001-3-26lld:pubmed
pubmed-article:11266081pubmed:abstractTextMutations of the flavin-containing monooxygenase type 3 gene (FMO3) that encode the major functional form present in adult human liver, have been shown to cause trimethylaminuria. We now report a novel homozygous deletion of exons 1 and 2 in an Australian of Greek ancestry with TMAuria, the first report of a deletion causative of trimethylaminuria. The deletion occurs 328 bp upstream from exon 1. The 3'-end of the deletion occurs in intron 2, 10013 base pairs downstream from the end of exon 2. The deletion is 12226 bp long. For the proband homozygous for the human FMO3 gene deletion, it is predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as TMA and other amines, the proband will exhibit decreased tolerance of biogenic amines, both medicinal and those found in foods.lld:pubmed
pubmed-article:11266081pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:languageenglld:pubmed
pubmed-article:11266081pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:citationSubsetIMlld:pubmed
pubmed-article:11266081pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11266081pubmed:statusMEDLINElld:pubmed
pubmed-article:11266081pubmed:monthMarlld:pubmed
pubmed-article:11266081pubmed:issn0960-314Xlld:pubmed
pubmed-article:11266081pubmed:authorpubmed-author:KnightMMlld:pubmed
pubmed-article:11266081pubmed:authorpubmed-author:ForrestS MSMlld:pubmed
pubmed-article:11266081pubmed:authorpubmed-author:AkermanB RBRlld:pubmed
pubmed-article:11266081pubmed:authorpubmed-author:CashmanJ RJRlld:pubmed
pubmed-article:11266081pubmed:authorpubmed-author:TreacyE PEPlld:pubmed
pubmed-article:11266081pubmed:issnTypePrintlld:pubmed
pubmed-article:11266081pubmed:volume11lld:pubmed
pubmed-article:11266081pubmed:ownerNLMlld:pubmed
pubmed-article:11266081pubmed:authorsCompleteYlld:pubmed
pubmed-article:11266081pubmed:pagination169-74lld:pubmed
pubmed-article:11266081pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:meshHeadingpubmed-meshheading:11266081...lld:pubmed
pubmed-article:11266081pubmed:year2001lld:pubmed
pubmed-article:11266081pubmed:articleTitleA novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria.lld:pubmed
pubmed-article:11266081pubmed:affiliationMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia. forrest@cryptic.rch.unimelb.edu.aulld:pubmed
pubmed-article:11266081pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11266081pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11266081pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:11266081pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2328entrezgene:pubmedpubmed-article:11266081lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11266081lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11266081lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11266081lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11266081lld:pubmed